This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Miltenyi Biotec, Gmbh, Deutsches Rheuma-Forschungszentrum Berlin, Leibniz Institute for Natural Product Research and Infection Biology—hans Knoll Institute. Active years: 2014-2022.
Location History:
- Berlin, DE (2017)
- Joachim Friedrich, DE (2019)
- Cologne, DE (2014 - 2022)
Company Filing History:
4 out of 65 
1 out of 11 
1 out of 1 Years Active: 2014-2022
Title: Innovations of Alexander Scheffold: A Pioneer in Immunotherapy
Introduction: Alexander Scheffold is a notable inventor based in Cologne, Germany, recognized for his significant contributions to the field of immunotherapy. With a total of five patents to his name, he has developed groundbreaking technologies that enhance treatment methodologies in the medical sector.
Latest Patents: Among his latest patents is a pioneering device titled "Systems and methods for point/center-of-care immunotherapy." This invention includes a cell modification device featuring a centrifugation chamber with specific design elements aimed at optimizing cell manipulation. The device operates by immobilizing cells on specialized surfaces via centrifugal force, making it portable and suitable for point-of-care applications. Another remarkable patent introduced by Scheffold is the "Method for polyclonal stimulation of T cells by flexible nanomatrices." This method entails utilizing nanomatrices to stimulate T cells effectively. The nanomatrix is designed from polymeric materials and facilitates the attachment of stimulatory agents that activate and promote the proliferation of T cells, demonstrating its potential for advanced immunotherapeutic interventions.
Career Highlights: Scheffold has had an impressive career, working with leading firms like Miltenyi Biotec and the Leibniz Institute for Natural Product Research and Infection Biology—Hans Knoll Institute. His work in these organizations has allowed him to push the envelope of innovation in cellular therapies and immunology.
Collaborations: Throughout his career, Scheffold has collaborated with esteemed professionals in his field, including notable figures such as Stefan Miltenyi and Timothy Wayne Waters. Their collective efforts have fostered an environment of innovation, resulting in advancements that are rapidly influencing the landscape of immunotherapy.
Conclusion: Alexander Scheffold's dedication to scientific innovation and his extensive work in immunotherapy exemplify the essence of pioneering research. With five patents highlighting his inventive contributions, he continues to shape the future of medical treatments, promoting better health outcomes through advanced technology. His inventions, particularly in cell modification and T cell stimulation, will undoubtedly pave the way for new therapeutic strategies.